AI주식인사이트AI Stock Insight
B

우진비앤지

018620KOSDAQ

61.8 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40
News Sentiment21.3 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 5.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Ujin B&G is a specialized company in animal pharmaceuticals, producing medications, vaccines, and supplements, with 35% of its sales coming from exports. Its subsidiaries, OSPI and Bawow Korea, manufacture pet food and treats, and the company aims to expand its market share through eco-friendly products and vaccine development.

Number of Employees

103people

Average Salary

54.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.30Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-5.38Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
24.70Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼2.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼25.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -4.2% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position6.0Point

52w upper range (76%)

Current 2,755Won52-week high 3,40052-week low 670
1-month return4.0Point

1m +5.15% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-25
  • Neutral주식등의대량보유상황보고서(일반)2026-08-25
  • Neutral반기보고서 (2026.06)2026-08-14